Plasma resistin levels associate with risk for hypertension among nondiabetic women

Journal of the American Society of Nephrology

Volumn 21, Issue 7, 2010, Pages 1185-1191

  Zhang, Luxia ^a,b   Curhan, Gary C ^a   Forman, John P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; RESISTIN; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR ADHESION PROTEIN 1;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 77954594164     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009101053     Document Type: Article

References (34)

1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 409: 307-312, 2001 (Pubitemid 32151228)
2. Koerner A, Kratzsch J, Kiess W: Adipocytokines: Leptin - the classical, resistin - the controversial, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19: 525-546, 2005
3. Rea R, Donnelly R: Resistin: An adipocyte-derived hormone - Has it a role in diabetes and obesity? Diabetes Obes Metab 6: 163-170, 2004 (Pubitemid 38559695)
4. Nagaev I, Smith U: Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285: 561-564, 2001
5. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300: 472-476, 2003
6. Yura S, Sagawa N, Itoh H, Kakui K, Nuamah MA, Korita D, Takemura M, Fujii S: Resistin is expressed in the human placenta. J Clin Endocrinol Metab 88: 1394-1397, 2003
7. Yang RZ, Huang Q, Xu A, McLenithan JC, Eisen JA, Shuldiner AR, Alkan S, Gong DW: Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 310: 927-935, 2003
8. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol 174: 5789-5795, 2005 (Pubitemid 40593223)
9. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108: 736-740, 2003
10. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R: Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: A new insight into adipocytokineendothelial cell interactions. Biochem Biophys Res Commun 314: 415-419, 2004
11. Calabro P, Samudio I, Willerson JT, Yeh ET: Resistin promotes smooth muscle cell proliferation through activation of extracellular signalregulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110: 3335-3340, 2004
12. Grundy SM: Inflammation, hypertension, and the metabolic syndrome. JAMA 290: 3000-3002, 2003
13. Oparil S, Zaman MA, Calhoun DA: Pathogenesis of hypertension. Ann Intern Med 139: 761-776, 2003
14. Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M, Nishida W, Okura T, Higaki J, Makino H: Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 51: 534-539, 2008
15. Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, Stavroulakis G, Hatzizacharias AN, Perrea D, Votteas VV: Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens (Greenwich) 7: 729-733, 2005
16. Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C: Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg 41: 691-698, 2005 (Pubitemid 40637670)
17. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ: Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932-939, 2005
18. Furuhashi M, Ura N, Higashiura K, Murakami H, Shimamoto K: Circulating resistin levels in essential hypertension. Clin Endocrinol (Oxf) 59: 507-510, 2003
19. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ: Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 52: 818-827, 2008
20. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, Mantzoros CS: Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88: 1730-1736, 2003 (Pubitemid 36623396)
21. Sowers MR, Wildman RP, Mancuso P, Eyvazzadeh AD, Karvonen-Gutierrez CA, Rillamas-Sun E, Jannausch ML: Change in adipocytokines and ghrelin with menopause. Maturitas 59: 149-157, 2008
22. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA: Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161: 1581-1586, 2001
23. Dimitriadis K, Tsioufis C, Selima M, Tsiachris D, Miliou A, Kasiakogias A, Andrikou E, Tousoulis D, Stefanadis C: Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. J Hum Hypertens 23: 668-673, 2009
24. Ellington AA, Malik AR, Klee GG, Turner ST, Rule AD, Mosley TH Jr, Kullo IJ: Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 50: 708-714, 2007
25. Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, Manson JE, Stampfer MJ, Curhan GC: Kidney dysfunction, inflammation, and coronary events: A prospective study. J Am Soc Nephrol 15: 1897-1903, 2004
26. Knight EL, Stampfer MJ, Rimm EB, Hankinson SE, Curhan GC: Moderate alcohol intake and renal function decline in women: A prospective study. Nephrol Dial Transplant 18: 1549-1554, 2003
27. Weikert C, Westphal S, Luley C, Willich SN, Boeing H, Pischon T: Within-subject variation of plasma resistin levels over a 1-year period. Clin Chem Lab Med 45: 899-902, 2007
28. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, Mantzoros CS, Hu FB: Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 149: 307-316, 2008
29. Kaplan RC, Ho GY, Xue X, Rajpathak S, Cushman M, Rohan TE, Strickler HD, Scherer PE, Anastos K: Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 16: 1291-1293, 2007
30. Willett W, Stampfer MJ: Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol 124: 17-27, 1986 (Pubitemid 16095831)
31. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE: Reproducibility and validity of a semi-quantitative food frequency questionnaire. Am J Epidemiol 122: 51-65, 1985 (Pubitemid 15010435)
32. Williams CJ, Hu FB, Patel SR, Mantzoros CS: Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care 30: 1233-1240, 2007
33. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE: Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53: 693-700, 2004 (Pubitemid 38270639)
34. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE: Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123: 894-900, 1986